CAC 40
7 628,57 -42,77 (-0,56 %) Euro Stoxx 50
4 907,30 -40,43 (-0,82 %) Dow Jones
39 150,33 +15,53 (+0,04 %) EUR/USD
1,0697 -0,0009 (-0,09 %) Gold future
2 334,70 -34,30 (-1,45 %) Bitcoin EUR
59 909,48 -209,25 (-0,35 %)
Olympus Corporation (OLYMY)
Olympus Corporation
Shinjuku Monolith
3-1 Nishi-Shinjuku 2-chome Shinjuku-ku
Tokyo 163-0914
Japan
81 3 3340 2111
https://www.olympus-global.com
Secteur(s): Healthcare
Secteur d’activité: Medical Instruments & Supplies
Employés à temps plein:
Description
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.
Gouvernance d’entreprise
L’ISS Governance QualityScore de Olympus Corporation en date du 1 juin 2024 est 1. Les scores principaux sont Audit : 1; Société : 1; Droits des actionnaires : 5; Compensation : 1.
